{"url_path":"/sec/bdpt/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1575142/0001640334-26-000911-index.html","accession_number":"0001640334-26-000911","cik":"0001575142","ticker":"BDPT","issuer_name":"BIOADAPTIVES, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1575142/0001640334-26-000911-index.html","primary_entity_key":"0001575142","primary_entity_name":"BIOADAPTIVES, INC."},"word_count":97,"has_tables":true,"body_markdown":"**Item 6. Exhibits**\n\n \n\n[31.1](bdpt_ex311.htm)\n\n \n[Section 302 Certification by the Principal Executive Officer](bdpt_ex311.htm)\n\n \n\n \n\n \n\n[31.2](bdpt_ex312.htm)\n\n \n[Section 302 Certification by the Principal Financial Officer](bdpt_ex312.htm)\n\n \n\n \n\n \n\n[32.1](bdpt_ex321.htm)\n\n \n[Section 906 Certification by the Principal Executive Officer](bdpt_ex321.htm)\n\n \n\n \n\n \n\n[32.2](bdpt_ex322.htm)\n\n \n[Section 906 Certification by the Principal Financial Officer](bdpt_ex322.htm)\n\n \n\n \n\n24\n\n*Table of Contents*\n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.\n\n \n\n \nBioAdaptives Inc. \n\n(Registrant)\n\n    \n\nDated: May 15, 2026 /s/ *James E. Keener*\n\n \n\n \nJames E. Keener \n\n  Chief Executive Officer \n\n \n\n \n\n25"}